← Back to Search

Etonogestrel Implant for Emergency Birth Control

Phase 4
Recruiting
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial is a single site, single arm, open label mechanism of action pharmacodynamic pilot study of etonogestrel implant insertion prior to an luteinizing hormone (LH) surge, in order to evaluate the effect on ovulation rates.

Eligible Conditions
  • Birth Control

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ovarian follicle size
Serum progesterone
Secondary outcome measures
Luteinizing hormone

Side effects data

From 2022 Phase 4 trial • 5 Patients • NCT04463693
80%
One week post-insertion site discomfort
60%
Intermittent uterine bleeding
20%
Persistent bothersome uterine bleeding
100%
80%
60%
40%
20%
0%
Study treatment Arm
Etonogestrel Implant

Trial Design

1Treatment groups
Experimental Treatment
Group I: Main cohortExperimental Treatment1 Intervention
Insertion of etonogestrel contraceptive implant prior to LH surge
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Etonogestrel
FDA approved

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,143,571 Total Patients Enrolled

Media Library

Etonogestrel implant Clinical Trial Eligibility Overview. Trial Name: NCT05237141 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitments still open for this clinical trial?

"Correct. According to the records on clinicaltrials.gov, this medical investigation kicked off on April 1st 2022 and is still currently recruiting participants. 12 candidates are required from a single location for enrolment into the trial."

Answered by AI

Could you elucidate on the potential risks of Etonogestrel implantation for patients?

"As this treatment is already approved, our internal assessment of etonogestrel's safety has been rated a 3."

Answered by AI

Are there any eligibility criteria for participation in this experiment?

"This clinical trial is enrolling 12 individuals aged 18-40 who have a pressing medical issue. To be considered, applicants must possess an undamaged uterus with at least one ovary; menstrual cycles that take place every 21 to 35 days; three periods after the second trimester of pregnancy or postpartum period if applicable; not pregnant and not trying to become so; BMI lower than 28kg/m2; one spontaneous menses following first trimester abortion or loss of pregnancy experiences, willingness to use etonogestrel contraceptive implant for birth control purposes and abstain from any medications/supplements known to either activate or suppress"

Answered by AI

How many participants are being included in this research study?

"Affirmative. Data hosted on clinicaltrials.gov reveals that this scientific investigation, which was initially posted on April 1st 2022, is actively recruiting participants. A total of 12 individuals need to be enrolled from a single test centre."

Answered by AI

Does this research project allow participants of 45 years and older to join?

"To be eligible for this trial, applicants must fall within the 18 to 40 year old age bracket. For those younger than 18 or older than 65, there are 60 and 172 respective studies offered."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Etonogestrel Implant as Emergency Contraception
2022. "Etonogestrel Implant as Emergency Contraception". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05237141.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top